Is GNW a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Enact cash flow and the holding company discount, with revenue (ttm) at ~$7.4 billion. The bear case rests on the core risk is that the long-term care closed block turns out to cost more than reserved: morbidity, mortality, policyholder lapse behaviour and long-run interest rates all feed the reserve, and a deterioration can require capital that the holding company would rather deploy elsewhere. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The core risk is that the long-term care closed block turns out to cost more than reserved: morbidity, mortality, policyholder lapse behaviour and long-run interest rates all feed the reserve, and a deterioration can require capital that the holding company would rather deploy elsewhere. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. Walnut is not an investment adviser.

Enact cash flow and the holding company discount. Enact is a well-capitalised mortgage insurer with a seasoned insurance-in-force book, and its dividends and buyback participation are Genworth's primary source of cash.

The core risk is that the long-term care closed block turns out to cost more than reserved: morbidity, mortality, policyholder lapse behaviour and long-run interest rates all feed the reserve, and a deterioration can require capital that the holding company would rather deploy elsewhere. Rate increases are approved one state at a time, so the multi-year rate action plan can slow without warning. Because Enact supplies almost all earnings and cash, a US housing downturn would hit Genworth twice, through mortgage delinquencies and through the market value of the stake itself. There is no announced plan to divest or distribute Enact, so the holding company discount can persist for years regardless of what the parts are worth. Genworth also remains a defendant in policyholder class actions over long-term care rate increase disclosures, and while the long-running securities class action was dismissed on summary judgment in August 2026, litigation outcomes are outside the company's control.

Holding company whose value sits in an approximately 81 percent stake in mortgage insurer Enact, offset by a legacy long-term-care runoff block.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Enact cash flow and the holding company discount) stalling in the reported numbers rather than in the narrative, the risk above (the core risk is that the long-term care closed block turns out to cost more than reserved: morbidity, mortality, policyholder lapse behaviour and long-run interest rates all feed the reserve, and a deterioration can require capital that the holding company would rather deploy elsewhere) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Genworth is a holding company with three parts. It owns ~81% of Enact Holdings, a listed private mortgage insurer that provides nearly all group operating earnings. It runs off a closed block of long-term care insurance sold decades ago and no longer offered on those terms, plus a smaller life and annuity block. And it is building CareScout, a network of vetted home care and senior living providers with an insurance arm writing new long-term care coverage.

At Enact's ~$6.9 billion market value, Genworth's ~81% is worth roughly $5.5 billion against a GNW market cap of ~$3.84 billion. The gap is the market's price for the long-term care closed block, holding company debt and corporate costs, and the uncertainty that the stake will ever be converted into cash for holders. Discounts like this can narrow through repurchases or a structural move, or persist for years.

It is a portfolio of long-term care policies written mostly between the 1970s and the 2000s, priced before insurers understood how long claimants would live and how few would lapse. Genworth stopped writing on those terms and now manages the block down over decades, collecting premiums and paying claims. It still records losses because original pricing was too low, which is exactly what the rate action plan exists to fix.